Leap Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LPTX and other ETFs, options, and stocks.

About LPTX

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer. 

CEO
Doug E. Onsi
CEODoug E. Onsi
Employees
52
Employees52
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2011
Founded2011
Employees
52
Employees52

LPTX Key Statistics

Market cap
13.35M
Market cap13.35M
Price-Earnings ratio
-0.19
Price-Earnings ratio-0.19
Dividend yield
—
Dividend yield—
Average volume
1.00M
Average volume1.00M
High today
$0.3236
High today$0.3236
Low today
$0.2814
Low today$0.2814
Open price
$0.2865
Open price$0.2865
Volume
810.74K
Volume810.74K
52 Week high
$4.79
52 Week high$4.79
52 Week low
$0.2223
52 Week low$0.2223

People also own

Based on the portfolios of people who own LPTX. This list is generated using Robinhood data, and it’s not a recommendation.
Tilray Brands
SNDL
Plug Power
Lucid Group
Mullen Automotive
Ocugen, Inc
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.